Row2019 	2018
Row$ 1,023 	$ 785
Row7,226 	6,573
Row9,333 	9,565
Row1,118 	923
Row18,700 	17,846
Row13,478 	13,911
Row16,560 	16,914
Row10,876 	11,783
Row6,851 	6,610
Row1,133 	1,060
Row48,899 	50,278
Row$ 67,598 	$ 68,124
Row$ 	5,738 	$ 	1,966
Row	14,341 5,474 216 25,769 11,098 1,785 4,795 17,678 		13,566
5,862
273
21,667
12,431
1,815
5,522
19,768
RowCommon stock $.01 par value; authorized 3.2 billion shares; issued 1,172,513,618 at August 31,
	Row2019 and 2018 	12 12
RowPaid-in capital 	10,639 10,493
RowRetained earnings 	35,815 33,551
RowAccumulated other comprehensive loss 	(3,897) (3,002)
RowTreasury stock, at cost; 277,126,116 shares at August 31, 2019 and 220,380,200 shares at
	RowAugust 31, 2018 	(19,057) (15,047)
RowTotal Walgreens Boots Alliance, Inc. shareholders’ equity 	23,512 26,007
RowNoncontrolling interests 	641 682
RowTotal equity 	24,152 26,689
RowTotal liabilities and equity 	$ 67,598 $ 68,124
Row	12 10,639 35,815 (3,897) (19,057) 23,512 	12
10,493
33,551
(3,002)
(15,047)
26,007
Row$ 	641 24,152 67,598 	682
26,689
$ 68,124
RowAugust 31, 2016 	1,082,986,591 Common stock
shares
	$12 Common
stock
amount
	$ (4,934) Treasury
stock
amount
	$10,111 Paid-in
capital
	$ (1) stock
loan
receivable
	$(2,992) other
comprehensive
income (loss)
	$27,684 Retained
earnings
	$ 401 Noncontrolling
interests
	Total
equity
$30,281
RowNet earnings Other comprehensive
income (loss), net of
	— 	— 	— 	— 	— 	— 	4,078 	23 	4,101
Rowtax Dividends declared and
	— 	— 	— 	— 	— 	(59) 	— 	(36) 	(95)
Rowdistributions Treasury stock
	— 	— 	— 	— 	— 	— 	(1,625) 	(98) 	(1,723)
Rowpurchases Employee stock
purchase and option
	(64,589,677) 	— 	(5,220) 	— 	— 	— 	— 	— 	(5,220)
Rowplans Stock-based
	5,452,156 	— 	183 	34 	1 	— 	— 	— 	218
Rowcompensation Noncontrolling interests
acquired and arising
on business
	— 		— 	91 	— 	— 	— 	— 	91
Rowcombinations 	— 	— 	— 	103 	— 	— 	— 	518 	621
RowAugust 31, 2017 	1,023,849,070 	$12 	$ (9,971) 	$10,339 	$— 	$(3,051) 	$30,137 	$ 808 	$28,274
RowNet earnings Other comprehensive
income (loss), net of
	— 	— 	— 	— 	— 	— 	5,024 	7 	5,031
Rowtax Dividends declared and
	— 	— 	— 	— 	— 	49 	— 	1 	50
Rowdistributions Treasury stock
	— 	— 	— 	— 	— 	— 	(1,610) 	(138) 	(1,748)
Rowpurchases Employee stock
	(76,069,557) 	— 	(5,228) 	— 	— 	— 	— 	— 	(5,228)
Rowpurchase and option
plans Stock-based
	4,353,905 	— 	152 	22 	— 	— 	— 	— 	174
Rowcompensation Noncontrolling interests
	— 	— 	— 	130 	— 	— 	— 	— 	130
Rowcontribution and other 	— 	— 	— 	2 	— 	— 	— 	4 	6
RowAugust 31, 2018 	952,133,418 	$12 	$ (15,047) 	$10,493 	$— 	$(3,002) 	$33,551 	$ 682 	$26,689
RowNet earnings Other comprehensive
income (loss), net of
	— 	— 	— 	— 	— 	— 	3,982 	(20) 	3,962
Rowtax Dividends declared and
	— 	— 	— 	— 	— 	(896) 	— 	(13) 	(909)
Rowdistributions Treasury stock
	— 	— 	— 	— 	— 	— 	(1,629) 	(3) 	(1,632)
Rowpurchases Employee stock
purchase and option
	(61,723,456) 	— 	(4,160) 	— 	— 	— 	— 	— 	(4,160)
Rowplans Stock-based
	4,977,540 	— 	150 	24 	— 	— 	— 	— 	174
Rowcompensation Adoption of new
	— 	— 	— 	119 	— 	— 	— 	— 	119
Rowaccounting standards Noncontrolling interests
	— 	— 	— 	— 	— 	— 	(88) 	— 	(88)
Rowcontribution and other 	— 	— 	— 	3 	— 	— 	(1) 	(5) 	(3)
RowAugust 31, 2019 	895,387,502 	$12 	$(19,057) 	$10,639 	$— 	$(3,897) 	$35,815 	$ 641 	$24,152
Row2019 	2018 	2017
Row$136,866 	$131,537 	$118,214
Row106,790 	100,745 	89,052
Row30,076 	30,792 	29,162
Row25,242 	24,694 	23,813
Row164 	191 	135
Row4,998 	6,289 	5,484
Row233 	302 	62
Row5,231 	6,591 	5,546
Row704 	616 	693
Row4,527 	5,975 	4,853
Row588 	998 	760
Row23 	54 	8
Row3,962 	5,031 	4,101
Row(20) 	7 	23
Row$ 3,982 	$ 5,024 	$ 4,078
Row$ 4.32 	$ 5.07 	$ 3.80
Row$ 4.31 	$ 5.05 	$ 3.78
Row921.5 	991.0 	1,073.5
Row923.5 	995.0 	1,078.5
RowSales 	2019 $136,866 	2018 $131,537 	2017
$118,214
RowCost of sales 	106,790 	100,745 	89,052
RowGross profit 	30,076 	30,792 	29,162
RowSelling, general and administrative expenses 	25,242 	24,694 	23,813
RowEquity earnings in AmerisourceBergen 	164 	191 	135
RowOperating income 	4,998 	6,289 	5,484
RowOther income 	233 	302 	62
RowEarnings before interest and income tax provision 	5,231 	6,591 	5,546
RowInterest expense, net 	704 	616 	693
RowEarnings before income tax provision 	4,527 	5,975 	4,853
RowIncome tax provision 	588 	998 	760
RowPost tax earnings from other equity method investments 	23 	54 	8
RowNet earnings 	3,962 	5,031 	4,101
RowNet (loss) earnings attributable to noncontrolling interests 	(20) 	7 	23
RowNet earnings attributable to Walgreens Boots Alliance, Inc. 	$ 3,982 $ 	5,024 	$ 4,078
RowNet earnings per common share:
			RowBasic 	$ 4.32 $ 	5.07 	$ 3.80
RowDiluted 	$ 4.31 $ 	5.05 	$ 3.78
RowWeighted average common shares outstanding:
Basic 	921.5 	991.0 	1,073.5
RowDiluted 	923.5 	995.0 	1,078.5
RowThe accompanying notes to Consolidated Financial Statements are an 	integral part of these 	Statements.
	RowComprehensive income:
	2019 	2018 	2017
RowNet earnings 	$3,962 	$5,031 	$4,101
RowOther comprehensive income (loss), net of tax:
			RowPension/postretirement obligations 	(149) 	240 	73
RowUnrealized gain on cash flow hedges 	60 	3 	4
RowUnrecognized (loss) on available-for-sale investments 	— 	— 	(2)
RowShare of other comprehensive income (loss) of equity method investments 	(1) 	5 	(1)
RowCurrency translation adjustments 	(820) 	(198) 	(169)
RowTotal other comprehensive income (loss) 	(909) 	50 	(95)
RowTotal comprehensive income 	3,053 	5,081 	4,006
RowComprehensive income (loss) attributable to noncontrolling interests 	(33) 	8 	(13)
RowComprehensive income attributable to Walgreens Boots Alliance, Inc. 	$3,086 	$5,073 	$4,019
Row2019 	2018 	2017
Row$3,962 	$5,031 	$4,101
Row(149) 	240 	73
Row60 	3 	4
Row— 	— 	(2)
Row(1) 	5 	(1)
Row(820) 	(198) 	(169)
Row(909) 	50 	(95)
Row3,053 	5,081 	4,006
Row(33) 	8 	(13)
Row$3,086 	$5,073 	$4,019
RowCash 	flows from operating activities:
Net earnings Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization Gain on previously held equity interest Deferred income taxes 	2019 $ 3,962 2,038 — 100 	2018 $ 5,031 1,770 (337) (322) 	2017
$ 4,101
1,654
—
(434)
Row	Stock compensation expense Equity earnings from equity method investments Other Changes in operating assets and liabilities:
Accounts receivable, net Inventories Other current assets 	119 (187) 302 (789) 141 (112) 	130 (244) 296 (391) 331 (22) 	91
(143)
364
(153)
98
—
RowCash 	Trade accounts payable Accrued expenses and other liabilities Income taxes Other non-current assets and liabilities Net cash provided by operating activities flows from investing activities:
Additions to property, plant and equipment 	954 (374) (406) (154) 5,594 (1,702) 	1,352 287 694 (311) 8,263 (1,367) 	1,684
(128)
44
77
7,255
(1,351)
RowCash 	Proceeds from sale leaseback transactions Proceeds from sale of other assets Business, investment and asset acquisitions, net of cash acquired Other Net cash used for investing activities flows from financing activities:
	3 117 (741) 16 (2,307) 	— 655 (4,793) 4 (5,501) 	444
59
(88)
93
(843)
Row	Net change in short-term debt with maturities of 3 months or less Proceeds from debt Payments of debt Stock purchases Proceeds related to employee stock plans 	536 12,433 (10,461) (4,160) 174 	586 5,900 (4,890) (5,228) 174 	33
—
(6,196)
(5,220)
217
RowChanges 	Cash dividends paid Other Net cash used for financing activities Effect of exchange rate changes on cash, cash equivalents and restricted cash in cash, cash equivalents and restricted cash
	(1,643) 75 (3,047) (9) 	(1,739) (98) (5,295) 11 	(1,723)
(45)
(12,934)
26
Row	Net increase (decrease) in cash, cash equivalents, and restricted cash Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period 	232 975 $ 1,207 	(2,522) 3,496 $ 975 	(6,496)
9,992
$ 3,496
Row$ 3,962 	$ 5,031 	$ 4,101
Row2,038 	1,770 	1,654
Row— 	(337) 	—
Row100 	(322) 	(434)
Row119 	130 	91
Row(187) 	(244) 	(143)
Row302 	296 	364
Row(789) 	(391) 	(153)
Row141 	331 	98
Row(112) 	(22) 	—
Row954 	1,352 	1,684
Row(374) 	287 	(128)
Row(406) 	694 	44
Row(154) 	(311) 	77
Row5,594 	8,263 	7,255
Row(1,702) 	(1,367) 	(1,351)
Row3 	— 	444
Row117 	655 	59
Row(741) 	(4,793) 	(88)
Row16 	4 	93
Row(2,307) 	(5,501) 	(843)
Row536 	586 	33
Row12,433 	5,900 	—
Row(10,461) 	(4,890) 	(6,196)
Row(4,160) 	(5,228) 	(5,220)
Row174 	174 	217
Row(1,643) 	(1,739) 	(1,723)
Row75 	(98) 	(45)
Row(3,047) 	(5,295) 	(12,934)
Row(9) 	11 	26
Row232 	(2,522) 	(6,496)
Row975 	3,496 	9,992
Row$ 1,207 	$ 975 	$ 3,496
Row2019 	2018
Row$ 1,023 	$ 785
Row7,226 	6,573
Row9,333 	9,565
Row1,118 	923
Row18,700 	17,846
Row13,478 	13,911
Row16,560 	16,914
Row10,876 	11,783
Row6,851 	6,610
Row1,133 	1,060
Row48,899 	50,278
Row$ 67,598 	$ 68,124
Row$ 	5,738 	$ 	1,966
Row	14,341 5,474 216 25,769 11,098 1,785 4,795 17,678 		13,566
5,862
273
21,667
12,431
1,815
5,522
19,768
RowCommon stock $.01 par value; authorized 3.2 billion shares; issued 1,172,513,618 at August 31,
	Row2019 and 2018 	12 12
RowPaid-in capital 	10,639 10,493
RowRetained earnings 	35,815 33,551
RowAccumulated other comprehensive loss 	(3,897) (3,002)
RowTreasury stock, at cost; 277,126,116 shares at August 31, 2019 and 220,380,200 shares at
	RowAugust 31, 2018 	(19,057) (15,047)
RowTotal Walgreens Boots Alliance, Inc. shareholders’ equity 	23,512 26,007
RowNoncontrolling interests 	641 682
RowTotal equity 	24,152 26,689
RowTotal liabilities and equity 	$ 67,598 $ 68,124
Row	12 10,639 35,815 (3,897) (19,057) 23,512 	12
10,493
33,551
(3,002)
(15,047)
26,007
Row$ 	641 24,152 67,598 	682
26,689
$ 68,124
RowAugust 31, 2016 	1,082,986,591 Common stock
shares
	$12 Common
stock
amount
	$ (4,934) Treasury
stock
amount
	$10,111 Paid-in
capital
	$ (1) stock
loan
receivable
	$(2,992) other
comprehensive
income (loss)
	$27,684 Retained
earnings
	$ 401 Noncontrolling
interests
	Total
equity
$30,281
RowNet earnings Other comprehensive
income (loss), net of
	— 	— 	— 	— 	— 	— 	4,078 	23 	4,101
Rowtax Dividends declared and
	— 	— 	— 	— 	— 	(59) 	— 	(36) 	(95)
Rowdistributions Treasury stock
	— 	— 	— 	— 	— 	— 	(1,625) 	(98) 	(1,723)
Rowpurchases Employee stock
purchase and option
	(64,589,677) 	— 	(5,220) 	— 	— 	— 	— 	— 	(5,220)
Rowplans Stock-based
	5,452,156 	— 	183 	34 	1 	— 	— 	— 	218
Rowcompensation Noncontrolling interests
acquired and arising
on business
	— 		— 	91 	— 	— 	— 	— 	91
Rowcombinations 	— 	— 	— 	103 	— 	— 	— 	518 	621
RowAugust 31, 2017 	1,023,849,070 	$12 	$ (9,971) 	$10,339 	$— 	$(3,051) 	$30,137 	$ 808 	$28,274
RowNet earnings Other comprehensive
income (loss), net of
	— 	— 	— 	— 	— 	— 	5,024 	7 	5,031
Rowtax Dividends declared and
	— 	— 	— 	— 	— 	49 	— 	1 	50
Rowdistributions Treasury stock
	— 	— 	— 	— 	— 	— 	(1,610) 	(138) 	(1,748)
Rowpurchases Employee stock
	(76,069,557) 	— 	(5,228) 	— 	— 	— 	— 	— 	(5,228)
Rowpurchase and option
plans Stock-based
	4,353,905 	— 	152 	22 	— 	— 	— 	— 	174
Rowcompensation Noncontrolling interests
	— 	— 	— 	130 	— 	— 	— 	— 	130
Rowcontribution and other 	— 	— 	— 	2 	— 	— 	— 	4 	6
RowAugust 31, 2018 	952,133,418 	$12 	$ (15,047) 	$10,493 	$— 	$(3,002) 	$33,551 	$ 682 	$26,689
RowNet earnings Other comprehensive
income (loss), net of
	— 	— 	— 	— 	— 	— 	3,982 	(20) 	3,962
Rowtax Dividends declared and
	— 	— 	— 	— 	— 	(896) 	— 	(13) 	(909)
Rowdistributions Treasury stock
	— 	— 	— 	— 	— 	— 	(1,629) 	(3) 	(1,632)
Rowpurchases Employee stock
purchase and option
	(61,723,456) 	— 	(4,160) 	— 	— 	— 	— 	— 	(4,160)
Rowplans Stock-based
	4,977,540 	— 	150 	24 	— 	— 	— 	— 	174
Rowcompensation Adoption of new
	— 	— 	— 	119 	— 	— 	— 	— 	119
Rowaccounting standards Noncontrolling interests
	— 	— 	— 	— 	— 	— 	(88) 	— 	(88)
Rowcontribution and other 	— 	— 	— 	3 	— 	— 	(1) 	(5) 	(3)
RowAugust 31, 2019 	895,387,502 	$12 	$(19,057) 	$10,639 	$— 	$(3,897) 	$35,815 	$ 641 	$24,152
Row2019 	2018 	2017
Row$136,866 	$131,537 	$118,214
Row106,790 	100,745 	89,052
Row30,076 	30,792 	29,162
Row25,242 	24,694 	23,813
Row164 	191 	135
Row4,998 	6,289 	5,484
Row233 	302 	62
Row5,231 	6,591 	5,546
Row704 	616 	693
Row4,527 	5,975 	4,853
Row588 	998 	760
Row23 	54 	8
Row3,962 	5,031 	4,101
Row(20) 	7 	23
Row$ 3,982 	$ 5,024 	$ 4,078
Row$ 4.32 	$ 5.07 	$ 3.80
Row$ 4.31 	$ 5.05 	$ 3.78
Row921.5 	991.0 	1,073.5
Row923.5 	995.0 	1,078.5
RowSales 	2019 $136,866 	2018 $131,537 	2017
$118,214
RowCost of sales 	106,790 	100,745 	89,052
RowGross profit 	30,076 	30,792 	29,162
RowSelling, general and administrative expenses 	25,242 	24,694 	23,813
RowEquity earnings in AmerisourceBergen 	164 	191 	135
RowOperating income 	4,998 	6,289 	5,484
RowOther income 	233 	302 	62
RowEarnings before interest and income tax provision 	5,231 	6,591 	5,546
RowInterest expense, net 	704 	616 	693
RowEarnings before income tax provision 	4,527 	5,975 	4,853
RowIncome tax provision 	588 	998 	760
RowPost tax earnings from other equity method investments 	23 	54 	8
RowNet earnings 	3,962 	5,031 	4,101
RowNet (loss) earnings attributable to noncontrolling interests 	(20) 	7 	23
RowNet earnings attributable to Walgreens Boots Alliance, Inc. 	$ 3,982 $ 	5,024 	$ 4,078
RowNet earnings per common share:
			RowBasic 	$ 4.32 $ 	5.07 	$ 3.80
RowDiluted 	$ 4.31 $ 	5.05 	$ 3.78
RowWeighted average common shares outstanding:
Basic 	921.5 	991.0 	1,073.5
RowDiluted 	923.5 	995.0 	1,078.5
RowThe accompanying notes to Consolidated Financial Statements are an 	integral part of these 	Statements.
	RowComprehensive income:
	2019 	2018 	2017
RowNet earnings 	$3,962 	$5,031 	$4,101
RowOther comprehensive income (loss), net of tax:
			RowPension/postretirement obligations 	(149) 	240 	73
RowUnrealized gain on cash flow hedges 	60 	3 	4
RowUnrecognized (loss) on available-for-sale investments 	— 	— 	(2)
RowShare of other comprehensive income (loss) of equity method investments 	(1) 	5 	(1)
RowCurrency translation adjustments 	(820) 	(198) 	(169)
RowTotal other comprehensive income (loss) 	(909) 	50 	(95)
RowTotal comprehensive income 	3,053 	5,081 	4,006
RowComprehensive income (loss) attributable to noncontrolling interests 	(33) 	8 	(13)
RowComprehensive income attributable to Walgreens Boots Alliance, Inc. 	$3,086 	$5,073 	$4,019
Row2019 	2018 	2017
Row$3,962 	$5,031 	$4,101
Row(149) 	240 	73
Row60 	3 	4
Row— 	— 	(2)
Row(1) 	5 	(1)
Row(820) 	(198) 	(169)
Row(909) 	50 	(95)
Row3,053 	5,081 	4,006
Row(33) 	8 	(13)
Row$3,086 	$5,073 	$4,019
RowCash 	flows from operating activities:
Net earnings Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization Gain on previously held equity interest Deferred income taxes 	2019 $ 3,962 2,038 — 100 	2018 $ 5,031 1,770 (337) (322) 	2017
$ 4,101
1,654
—
(434)
Row	Stock compensation expense Equity earnings from equity method investments Other Changes in operating assets and liabilities:
Accounts receivable, net Inventories Other current assets 	119 (187) 302 (789) 141 (112) 	130 (244) 296 (391) 331 (22) 	91
(143)
364
(153)
98
—
RowCash 	Trade accounts payable Accrued expenses and other liabilities Income taxes Other non-current assets and liabilities Net cash provided by operating activities flows from investing activities:
Additions to property, plant and equipment 	954 (374) (406) (154) 5,594 (1,702) 	1,352 287 694 (311) 8,263 (1,367) 	1,684
(128)
44
77
7,255
(1,351)
RowCash 	Proceeds from sale leaseback transactions Proceeds from sale of other assets Business, investment and asset acquisitions, net of cash acquired Other Net cash used for investing activities flows from financing activities:
	3 117 (741) 16 (2,307) 	— 655 (4,793) 4 (5,501) 	444
59
(88)
93
(843)
Row	Net change in short-term debt with maturities of 3 months or less Proceeds from debt Payments of debt Stock purchases Proceeds related to employee stock plans 	536 12,433 (10,461) (4,160) 174 	586 5,900 (4,890) (5,228) 174 	33
—
(6,196)
(5,220)
217
RowChanges 	Cash dividends paid Other Net cash used for financing activities Effect of exchange rate changes on cash, cash equivalents and restricted cash in cash, cash equivalents and restricted cash
	(1,643) 75 (3,047) (9) 	(1,739) (98) (5,295) 11 	(1,723)
(45)
(12,934)
26
Row	Net increase (decrease) in cash, cash equivalents, and restricted cash Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period 	232 975 $ 1,207 	(2,522) 3,496 $ 975 	(6,496)
9,992
$ 3,496
Row$ 3,962 	$ 5,031 	$ 4,101
Row2,038 	1,770 	1,654
Row— 	(337) 	—
Row100 	(322) 	(434)
Row119 	130 	91
Row(187) 	(244) 	(143)
Row302 	296 	364
Row(789) 	(391) 	(153)
Row141 	331 	98
Row(112) 	(22) 	—
Row954 	1,352 	1,684
Row(374) 	287 	(128)
Row(406) 	694 	44
Row(154) 	(311) 	77
Row5,594 	8,263 	7,255
Row(1,702) 	(1,367) 	(1,351)
Row3 	— 	444
Row117 	655 	59
Row(741) 	(4,793) 	(88)
Row16 	4 	93
Row(2,307) 	(5,501) 	(843)
Row536 	586 	33
Row12,433 	5,900 	—
Row(10,461) 	(4,890) 	(6,196)
Row(4,160) 	(5,228) 	(5,220)
Row174 	174 	217
Row(1,643) 	(1,739) 	(1,723)
Row75 	(98) 	(45)
Row(3,047) 	(5,295) 	(12,934)
Row(9) 	11 	26
Row232 	(2,522) 	(6,496)
Row975 	3,496 	9,992
Row$ 1,207 	$ 975 	$ 3,496
